Please login to the form below

Not currently logged in
Email:
Password:

The Access Partnership

This page shows the latest The Access Partnership news and features for those working in and with pharma, biotech and healthcare.

Horizon Discovery and C4X to harness CRISPR for new cancer drugs

Horizon Discovery and C4X to harness CRISPR for new cancer drugs

The partnership has been established to complete the target validation package for these novel targets, leading to the start of drug discovery programmes by C4XD should it exercise its options on ... The partnership gives C4XD access to Horizon’s

Latest news

  • MS and cholesterol drugs picked for new UK rapid uptake push MS and cholesterol drugs picked for new UK rapid uptake push

    Accelerated Access Partnership Rapid Uptake Products. The list as released by the Department of Health and Social Care and NICE, which is co-ordinating the ACC, including comments on the rationale ... While the ACC’s first rapid uptake list is welcome

  • Global Pricing Innovations and Partners4Access partner on market access Global Pricing Innovations and Partners4Access partner on market access

    Will collaborate on orphan drug pricing and access solutions. Global Pricing Innovations and Partners4Access have formed a strategic partnership to offer pricing and access solutions for orphan drugs. ... The common vision we share in creating innovative

  • OncoAssist becomes latest app to be classified as a medical device OncoAssist becomes latest app to be classified as a medical device

    OncoAssist is designed to save oncologists time by providing quick and easy access to prognostic tools that can help with decisions on risk stratification and clinical trial. ... The company said it was currently on the look out for partnership

  • Succinct forms market access partnership with Royal Marsden Succinct forms market access partnership with Royal Marsden

    Succinct Healthcare Communications has entered a market access partnership with London-based cancer research and treatment centre The Royal Marsden (TRM) NHS Foundation Trust. ... We are proud to have formed what we believe is a unique partnership

  • GSK and MaRS launch innovation fund

    The partnership will provide access to capitals and opportunities for early engagement with experts to guide and position technologies for successful commercialisation through licensing or start-up company creation. ... We hope that this collaboration

More from news
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Pharma deals in June 2015 Pharma deals in June 2015

    The X-BODY acquisition gives Juno access to an antibody discovery platform that allows rapid selection of fully human antibodies, even against difficult targets. ... In a rather different approach to drug delivery, Teva has entered into a partnership

  • Biosimilars: friend or foe for healthcare systems? Biosimilars: friend or foe for healthcare systems?

    White is director of global market access at the Access Partnership and can be contacted on tel: 44 208 0695252 or email him. ... Fleetwood is director of Therapy Watch at the Research Partnership and can be contacted on tel: 44 208 0695049 or email her.

  • Pharma–payer partnerships – rhetoric or reality? Pharma–payer partnerships – rhetoric or reality?

    global director at the Access Partnership, a global market access and consultancy agency. ... pascalk@access-partnership.com.

  • A new dogma in HTA assessment A new dogma in HTA assessment

    The partnership will give AstraZeneca access to pre-existing anonymised electronic health records, and the companies will jointly develop a customised research and data analysis platform. ... The partnership helped Novartis to design better studies and

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Sandoz UK promotes Tim de Gavre to country head Sandoz UK promotes Tim de Gavre to country head

    He said: “I am immensely proud to be asked to lead the Sandoz UK team. ... I look forward to working with the Sandoz team, and in partnership with the NHS to help patients access these important medicines.”.

  • Access Partnership expands its senior team Access Partnership expands its senior team

    Healthcare market access agency Access Partnership has added to its global senior team. ... The Access Partnership was launched last year by the Research Partnership. .

  • The Access Partnership hires Mike Mallinson The Access Partnership hires Mike Mallinson

    London-based  The Access Partnership, part of the The Research Partnership, has appointed Mike Mallinson as president of the market access consultancy firm. ... Our aim is for The Access Partnership to become the preferred commercial partner for

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Access and elimination: the future of DAAs in hepatitis C

    Published in Pharmaphorum January 2017. The dramatic improvements in safety, efficacy, tolerability and convenience from the first wave of direct-acting antivirals (DAAs) have made a substantial contribution to changing both ... The arrival of

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...
Understanding the evolving CAR-T market
In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in...

Infographics